CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $26.47M, lower than 95% of all stocks globally
- PositionReturn on equity is -78.6%, lower than 95% of its Medical Instruments & Supplies peers (median 5.6%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
26.47MUSDvs all stocks (USD)
Revenue (TTM)
85.53MUSDvs all stocks (USD)
Profit Margin
-11.44%vs Medical Instruments & Supplies peers
Beta
1.51xvs all stocks
52-Week Change
10.75%vs all stocks
Market Capitalization
26.47MUSDvs all stocks (USD)
Enterprise Value
63.86MUSDvs all stocks (USD)
Forward P/E
13.64xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
0.3164xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.69xvs Medical Instruments & Supplies peers
Enterprise to Revenue
0.7470xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
8.16xvs Medical Instruments & Supplies peers
Gross Margin
58.99%vs Medical Instruments & Supplies peers
Profit Margin
-11.44%vs Medical Instruments & Supplies peers
Operating Margin
-4.52%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.73%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-78.65%vs Medical Instruments & Supplies peers
Revenue (TTM)
85.53MUSDvs all stocks (USD)
Revenue per Share (TTM)
19.20USDUpdated Jul 9, 2026Quarterly Revenue Growth
-4.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
49.97MUSDvs all stocks (USD)
EBITDA (TTM)
2.28MUSDvs all stocks (USD)
Net Income (TTM)
-9.78MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-4.68%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
3.08MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
7.84MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 9, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Revenue
86.55MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
36.64MUSDFY2025 · Dec 31, 2025Gross Profit
49.91MUSDFY2025 · Dec 31, 2025Operating Income
100.00KUSDvs all stocks (USD)
Pre-tax Income
-57.39MUSDFY2025 · Dec 31, 2025Income Tax Expense
-686.00KUSDFY2025 · Dec 31, 2025Net Income
-56.70MUSDFY2025 · Dec 31, 2025EBIT
-52.47MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.16MUSDFY2025 · Dec 31, 2025Research & Development
8.82MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
36.96MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
4.92MUSDFY2025 · Dec 31, 2025EPS (Basic)
-1.28USDFY2025 · Dec 31, 2025EPS (Diluted)
-1.28USDFY2025 · Dec 31, 2025Basic Shares Outstanding
44.39MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
44.39MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-56.70MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-42.59MUSDFY2025 · Dec 31, 2025Free Cash Flow
-43.84MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
8.61MUSDFY2025 · Dec 31, 2025Interest Paid
3.60MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-56.70MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
5.95MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-680.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
1.85MUSDFY2025 · Dec 31, 2025Other Non-cash Items
1.32MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-934.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
2.30MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
4.31MUSDFY2025 · Dec 31, 2025Capital Expenditures
-1.26MUSDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.26MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
40.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-37.35MUSDFY2025 · Dec 31, 2025Other Financing Charges
-3.99MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.34MUSDFY2025 · Dec 31, 2025Shares Outstanding
4.51MSharesUpdated Jul 9, 2026Float Shares
3.53MSharesUpdated Jul 9, 2026Shares Short
106.20KSharesUpdated Jul 9, 2026Short Ratio
3.42daysvs all stocks
Short % of Shares Outstanding
2.39%vs all stocks
% Held by Insiders
9.48%vs all stocks
% Held by Institutions
45.05%vs all stocks
Total Cash (MRQ)
7.10MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.57USDUpdated Jul 9, 2026Total Debt (MRQ)
44.12MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
4.39xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.99xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
2.23USDUpdated Jul 9, 2026Total Assets
80.07MUSDvs all stocks (USD)
Total Current Assets
48.23MUSDFY2025 · Dec 31, 2025Total Liabilities
66.34MUSDFY2025 · Dec 31, 2025Total Non-current Assets
31.85MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
44.38MUSDFY2025 · Dec 31, 2025Total Current Liabilities
21.96MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
8.61MUSDFY2025 · Dec 31, 2025Accounts Receivable
16.04MUSDFY2025 · Dec 31, 2025Inventory
20.80MUSDFY2025 · Dec 31, 2025Accounts Payable
3.65MUSDFY2025 · Dec 31, 2025Short-term Debt
1.52MUSDFY2025 · Dec 31, 2025Deferred Revenue
3.45MUSDFY2025 · Dec 31, 2025Other Current Liabilities
11.52MUSDFY2025 · Dec 31, 2025Long-term Debt
42.75MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
1.31MUSDFY2025 · Dec 31, 2025Common Stock (Book)
447.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-214.71MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
13.73MUSDvs all stocks (USD)
52-Week Low
3.80USDUpdated Jul 9, 202652-Week High
9.40USDUpdated Jul 9, 202652-Week Change
10.75%vs all stocks
Beta
1.51xvs all stocks
50-Day MA
6.04USDUpdated Jul 9, 2026200-Day MA
5.70USDUpdated Jul 9, 2026Avg 10-Day Volume
21.37KSharesUpdated Jul 9, 2026Avg 30-Day Volume
31.65KSharesUpdated Jul 9, 2026Diluted EPS (TTM)
-2.15USDUpdated Jul 9, 2026Other Income / Expense
-52.57MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is -78.6%, lower than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: -0.79Industry median: 0.06Industry P5: -0.46Peers compared: 65.00
Debt-to-equity is 4.39×, higher than 95% of its Medical Instruments & Supplies peers (median 0.23×)Significant
Debt-to-equity: 4.39Industry median: 0.23Industry P95: 1.26Peers compared: 65.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.59Profit Margin: -0.11
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 1.99Altman Z-Score: -4.20
Financial Health
Altman Z-Score -4.2: distress zoneCritical
Altman Z-Score: -4.20
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $26.47M, lower than 95% of all stocks globallySignificant
Market cap (USD): 26,474,768Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Haydale Graphene Industries plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Light Science Technologies Holdings plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Northern Bear Plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Genedrive Plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Abingdon Health plc
Tier 1ProductionThroughput-Bound ConversionRule
Kropz PLC
Tier 1ProductionThroughput-Bound ConversionFlowRule
Windar Photonics PLC
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
CelLBxHealth plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Eco Buildings Group plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Verditek plc
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Shandong Longda Meishi Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators
China High-Speed Railway Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators
Yorhe Fluid Intelligent Control Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators